NCT02324127Unknown不适用
Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer
适应症
试验速览
- 阶段
- 不适用
- 发起方
- Protgen Ltd
- 入组人数
- 1,100
- 试验地点
- 1
- 主要终点
- Hsp90α Concentration of plasma
研究概览
简要总结
Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases.
详细描述
Detect plasma Hsp90α concentration of liver cancer patients, healthy volunteers, benign liver diseases, validate accuracy, specificity and sensitivity of Hsp90α kit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Liver cancer patients
- •Healthy volunteers,
- •Benign liver diseases patients
排除标准
- •Patients who Previously accepted radiotherapy
结局指标
主要结局
Hsp90α Concentration of plasma
时间窗: 4 months
Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal CancerColorectal CancerNCT02324114Protgen Ltd1,100
Unknown
不适用
Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast CancerBreast CancerNCT02324101Protgen Ltd1,100
Unknown
不适用
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCCCirrhosis, LiverHepatocellular CarcinomaLiver CancerNCT04221347Military University Hospital, Prague250
招募中
不适用
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion TherapyHepatocellular CarcinomaNCT06382103Shanghai Zhongshan Hospital240
已完成
不适用
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)Cirrhosis, LiverLiver CancerHepatocellular CarcinomaHepatic CirrhosisNCT03804593Epigenomics, Inc175